By respecting, valuing, and nurturing the brain health of asylum seekers and refugees, we can build healthier, more resilient communities.
Elena Stotts-Lee, William Hynes, Rym Ayadi, Luz Maria Garcini, Fadi Maalouf, Augustin Ibanez, Mohamed Salama, Rachel A. Meidl, Harris A. EyreMarch 21, 2024
The Biden administration’s new industrial policy initiatives aim to help the U.S. compete with China, battle climate change and provide middle class jobs. Will these policies work or fade away like previous efforts?
This brief examines the four economic pillars that are often credited with bolstering Mexico’s economy in 2019 and 2020 to determine how quickly the nation's economy will bounce back from the COVID-19 pandemic.
Tony Payan, Jose Ivan Rodriguez-SanchezApril 9, 2021
Jose Ivan Rodriguez-Sanchez, the postdoctoral research fellow in international trade for the Center for the U.S. and Mexico, analyzes the economic impact of COVID-19 travel restrictions on the tourism industry of Texas border counties, many of which depend on Mexicans entering the U.S. and spending billions of dollars each year.
Corruption is a complex social, political and institutional problem that is difficult to define. This brief describes the challenges involved in defining, understanding and measuring corruption and evaluates the case study of Mexico, where corruption has increased in recent years, to illustrate these complexities.
The author examines the key challenges and opportunities of integrating climate policies with Gulf Cooperation Council economic diversification strategies, particularly in Oman and the United Arab Emirates.
With the Texas Legislature now considering several bills that would decrease penalties for marijuana possession and legalize the use of medical marijuana to treat a variety of conditions, authors William Martin and Katharine A. Neill present updated findings in this new issue brief that support the case for reforming marijuana policy in Texas.
Katharine Neill Harris, William MartinMarch 10, 2017
Drug Policy Program director Bill Martin summarizes the scientific and fiscal evidence supporting the efficacy of syringe exchange programs and outlines a framework for public policies to deal with this aspect of drug use and abuse.